Connecticut · 2025 Regular Session · Bill

SB 1473: AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.

Enacted Last action June 23, 2025: SIGNED BY GOVERNOR

Plain-language summary

SB 1473 is a bill introduced in the Connecticut Senate on March 6, 2025. According to its official title, it concerns: AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE. Most recent recorded action (June 23, 2025): SIGNED BY GOVERNOR.

Sponsors

No sponsor recorded in the official data.